Obtaining data from clinical studies is necessary for the development of new products and to confirm the diagnosis capability and the clinical value of all Progenika products. All the studies are approved by the appropriate ethics and research committees following the legislation guidelines.
All studies are carried out with clinical researchers under a collaboration framework. Clinitians not only provide well-typed human samples according to strict authorized protocols, but also help in the design and many other aspects of the trials, such as the interpretation of data. Progenika supports multicentre clinical trials for which has established a network of collaborations with hospitals in Austria, The Czech Republic, France, Germany, Holland, Italy, Spain, Sweden, UK, Japan and USA.
Outstanding examples of the clinical consortia that have been created to validate the technical accuracy and the clinical utility of Progenika DNAchips include:
With the collaboration of:
